MedPath

University of Pennsylvania

University of Pennsylvania logo
🇺🇸United States
Ownership
Private
Established
1740-11-14
Employees
5K
Market Cap
-
Website
http://www.upenn.edu

Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic Disease

Not Applicable
Completed
Conditions
Hypertension
Obesity
Diabetes
Asthma/COPD With Tobacco Dependence
Interventions
Behavioral: CHW Goal Support
First Posted Date
2013-07-16
Last Posted Date
2017-05-03
Lead Sponsor
University of Pennsylvania
Target Recruit Count
302
Registration Number
NCT01900470
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Financial Incentives for Maintenance of Weight Loss

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Financial incentive
First Posted Date
2013-07-16
Last Posted Date
2018-09-27
Lead Sponsor
University of Pennsylvania
Target Recruit Count
191
Registration Number
NCT01900392
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Mood and Nutrition Interventions in Polycystic Ovary Syndrome

Not Applicable
Completed
Conditions
Polycystic Ovary Syndrome (PCOS)
Interventions
Behavioral: Cognitive Behavioral Therapy
Behavioral: Nutrition Counseling
First Posted Date
2013-07-15
Last Posted Date
2016-11-23
Lead Sponsor
University of Pennsylvania
Target Recruit Count
40
Registration Number
NCT01899001
Locations
🇺🇸

Penn PCOS Center, Philadelphia, Pennsylvania, United States

Ghrelin Plus Strength Training in Frail Elderly Study

Phase 2
Completed
Conditions
Frailty Syndrome
Interventions
Drug: Placebo
First Posted Date
2013-07-12
Last Posted Date
2019-12-11
Lead Sponsor
University of Pennsylvania
Target Recruit Count
16
Registration Number
NCT01898611
Locations
🇺🇸

Clinical and Translational Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Nicotine Metabolism and Little Cigars

Not Applicable
Completed
Conditions
Smoking
Interventions
Other: Switch to smoking only little cigars
First Posted Date
2013-07-12
Last Posted Date
2017-10-06
Lead Sponsor
University of Pennsylvania
Target Recruit Count
197
Registration Number
NCT01898559
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer

Phase 1
Completed
Conditions
Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
Interventions
Biological: Autologous T cells transfected with chimeric anti-mesothelin immunoreceptor SS1
First Posted Date
2013-07-12
Last Posted Date
2017-09-19
Lead Sponsor
University of Pennsylvania
Target Recruit Count
16
Registration Number
NCT01897415
Locations
🇺🇸

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Nicotine Metabolism and Low Nicotine Cigarettes

Not Applicable
Completed
Conditions
Smoking
Interventions
Other: Low nicotine cigarettes
First Posted Date
2013-07-12
Last Posted Date
2018-07-18
Lead Sponsor
University of Pennsylvania
Target Recruit Count
207
Registration Number
NCT01898507
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Partners and Alerts: A Study of Social Forces in Medication Adherence

Not Applicable
Completed
Conditions
Acute Myocardial Infarction (AMI)
Interventions
Behavioral: Electronic Pill Bottle tracking
Behavioral: Social Influence
Behavioral: Adherence Messaging
First Posted Date
2013-07-01
Last Posted Date
2017-11-17
Lead Sponsor
University of Pennsylvania
Target Recruit Count
178
Registration Number
NCT01890018
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes

Not Applicable
Completed
Conditions
Diabetes
First Posted Date
2013-06-25
Last Posted Date
2015-09-23
Lead Sponsor
University of Pennsylvania
Target Recruit Count
200
Registration Number
NCT01886170
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Phase 2
Completed
Conditions
Opiate Dependence
Human Immunodeficiency Virus
Interventions
Drug: placebo comparator
First Posted Date
2013-06-20
Last Posted Date
2020-11-06
Lead Sponsor
University of Pennsylvania
Target Recruit Count
77
Registration Number
NCT01882361
Locations
🇷🇺

Federal Medical Research Center for Psychiatry and Narcology (FMRC), Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath